1. Home
  2. ICCC vs PAI Comparison

ICCC vs PAI Comparison

Compare ICCC & PAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$10.24

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset Investment Grade Income Fund Inc.

PAI

Western Asset Investment Grade Income Fund Inc.

SELL

Current Price

$11.42

Market Cap

108.0M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ICCC
PAI
Founded
1982
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
93.1M
108.0M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ICCC
PAI
Price
$10.24
$11.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.6K
★ 25.1K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
★ 4.78%
EPS Growth
★ 53.85
N/A
EPS
★ 0.41
N/A
Revenue
★ $26,493,169.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$25.72
★ N/A
Revenue Growth
★ 51.64
N/A
52 Week Low
$4.52
$11.24
52 Week High
$12.10
$12.95

Technical Indicators

Market Signals
Indicator
ICCC
PAI
Relative Strength Index (RSI) 56.92 48.99
Support Level $9.45 $11.24
Resistance Level $10.82 $12.35
Average True Range (ATR) 0.24 0.09
MACD 0.01 0.02
Stochastic Oscillator 73.40 73.08

Price Performance

Historical Comparison
ICCC
PAI

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

About PAI Western Asset Investment Grade Income Fund Inc.

Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. Its primary investment objective is to seek a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. To a lesser extent, the fund also invests in privately placed debt securities and in certain equity securities. Capital appreciation is its secondary investment objective. The fund invests a majority of its net assets in fixed income securities that are rated in the Baa or BBB categories or above at the time of purchase by one or more Nationally Recognized Statistical Rating Organizations (NRSROs) or unrated securities of comparable quality at the time of purchase (as determined by the investment adviser).

Share on Social Networks: